OCIAD2 anticorps (N-Term)
Aperçu rapide pour OCIAD2 anticorps (N-Term) (ABIN500407)
Antigène
Voir toutes OCIAD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, mouse, rat
-
Purification
- Peptide affinity chromatography
-
Immunogène
- OCIAD2 antibody was raised against a 17 amino acid peptide from near the amino terminus of human OCIAD2.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
ELISA. Western blot: 0.5 - 1 μg/mL. Immunoflourescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store the antibody (in aliquots) at -20 °C.
-
-
- OCIAD2 (OCIA Domain Containing 2 (OCIAD2))
-
Autre désignation
- OCIAD2
-
Sujet
- OCIAD2 was identified by its sequence similarity with OCIAD1, and together OCIAD1 and OCIAD2 form the OCIA domain family. OCIAD2 mRNA was found to be expressed at higher levels in invasive adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component (BAC) of the lung. Loss of OCIAD2 expression was significantly correlated with lymphatic invasion, blood vessel invasion, and lymph node metastasis, indicating that OCIAD2 may play a role in cell adhesion and prevention of cell migration. While the function of OCIAD2 is still unknown, its expression in adenocarcinoma with BAC component is significantly associated with a favorable prognosis and may serve as a marker for selecting tumors that are treatable by limited surgery.Synonyms: OCIA domain-containing protein 2, Ovarian carcinoma immunoreactive antigen-like protein
-
ID gène
- 132299
-
NCBI Accession
- NP_001014446
-
UniProt
- Q56VL3
Antigène
-